cgp 54626 has been researched along with catechin in 1 studies
Studies (cgp 54626) | Trials (cgp 54626) | Recent Studies (post-2010) (cgp 54626) | Studies (catechin) | Trials (catechin) | Recent Studies (post-2010) (catechin) |
---|---|---|---|---|---|
57 | 0 | 16 | 11,544 | 477 | 6,612 |
Protein | Taxonomy | cgp 54626 (IC50) | catechin (IC50) |
---|---|---|---|
Arginase | Leishmania amazonensis | 1.7 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adachi, N; Denbow, DM; Furuse, M; Tachibana, T; Tomonaga, S | 1 |
1 other study(ies) available for cgp 54626 and catechin
Article | Year |
---|---|
(-)-Epigallocatechin gallate attenuates acute stress responses through GABAergic system in the brain.
Topics: Animals; Antioxidants; Brain; Catechin; Chickens; Corticosterone; Dose-Response Relationship, Drug; GABA Antagonists; GABA-B Receptor Antagonists; Injections, Intraventricular; Male; Organophosphorus Compounds; Picrotoxin; Receptors, GABA-B; Stress, Psychological; Vocalization, Animal | 2006 |